WANA (Sep 15) – An Iranian nanotechnology startup has developed a groundbreaking device based on the DAB method, transforming the production of biodegradable microneedles. This innovative technology, seen as a pain-free alternative to traditional injections, could play a significant role in vaccination, treatment of skin cancers, and even cosmetic and personal care products.

 

Needle-related pain and fear have long been barriers for patients receiving injections. For years, scientists have sought minimally invasive, painless drug delivery methods.

 

Biodegradable microneedle technology has emerged as a key solution: ultra-fine, bio-degradable needles placed on small patches that deliver medication gradually through the skin. Beyond vaccination, this technology has applications in skin cancer therapy and cosmetic products.

 

However, manufacturing microneedles has traditionally been challenging. Conventional production methods are multi-step, time-consuming, require expensive equipment, and limit material selection. The Iranian research team has addressed many of these issues with their new DAB-based device.

 

The system can produce biodegradable microneedles in just 15 minutes in a single step. Crucially, the process is automated and continuous, simplifying the path to industrial-scale production.

 

The project is led by Seyed Ali Mousavi Shaigh (CEO), Amirhossein Abbasi (Technical Director), and Amir Emad Kheiriyeh (Key Collaborator).

 

The team has successfully demonstrated the device’s functionality at the laboratory scale, producing microneedle patches with a 4×4 array. Over the next year, they plan to complete development and process optimization to prepare the product for industrial-scale manufacturing.

 

Unique features of this device set it apart from existing methods. Advantages include fewer production steps, ease of use, high scalability, and production costs reduced by up to 50 percent.

 

The team is currently building a desktop prototype (MVP) and aims to develop an industrial version suitable for export. This demonstrates that the technology is viable not only in the lab but also for large-scale commercial production.

 

According to Iran’s Nano Headquarters, the project is supported by the Vice-Presidency for Science, Technology, and Knowledge-Based Economy, as well as the Nano and Micro Technology Development Headquarters. These endorsements highlight the strategic importance of the technology and its high potential for commercialization and entry into the global market.

 

Experts note that biodegradable microneedles could transform drug delivery and vaccination. Reduced pain, ease of use, rapid production, and lower costs make this technology highly attractive for patients, healthcare providers, and the pharmaceutical industry.

Microneedle patches. Social media/ WANA News Agency

Microneedle patches. Social media/ WANA News Agency